Language: 🇺🇸 🇲🇽 🇷🇺
Washington educational resource

Washington MHMDA for Mental Health SaaS: Compliance Outside HIPAA

If you run a therapy app, mood tracker, journaling product, substance-use platform, peer-support community, AI mental health chatbot, or any behavioral health SaaS that touches Washington consumers, Chapter 19.373 RCW probably reaches you, and HIPAA usually does not. Most mental health SaaS sits outside HIPAA entirely because the operator is neither a covered entity nor a business associate. Washington's My Health My Data Act fills the gap and treats mental health status, mood, symptoms, diagnosis, treatment-seeking, journal entries, and inferences as consumer health data. A violation is a per se Consumer Protection Act violation under RCW 19.373.090. This hub walks the live compliance surface for behavioral health products.

Sergei Tokmakov, Esq., California attorney, CA Bar #279869
AI Legal Analyst

Ask my AI Legal Analyst about MHMDA for mental health SaaS?

Tap a question for an instant, free answer (no email needed), or describe your product and the analyst routes you to the right next step. Answers cover why this is the highest-risk category, the third-party SDK trap, and the compliance stack.

Common mental health SaaS questions, always free

Loading the AI Legal Analyst...

Key terms?

The mental health SaaS compliance surface turns on a handful of defined terms. Tap a card to flip it.

MHMDA defines consumer health data at as personal information linked or reasonably linkable to a consumer that identifies past, present, or future physical or mental health status, including inferences. Mental health is named expressly. The definition reaches the obvious categories (diagnosis, treatment, symptoms, medication) and also reaches the inputs and outputs of most mental health SaaS products: mood logs, journal entries, sleep and stress markers, PHQ-9 / GAD-7 / PCL-5 questionnaire results, crisis-language flags, and any AI inference drawn from non-clinical inputs.

Three reasons this category carries more exposure than ordinary wellness SaaS. First, most mental health products explicitly invite users to disclose mental health status, which removes any "we never collect health data" argument. Second, third-party SDKs (analytics, session replay, attribution pixels, CRM, AI APIs, customer support tooling) commonly receive content that is consumer health data, which converts marketing pixels and AI-API calls into MHMDA sharing events. Third, the per se CPA bridge in means a plaintiff does not have to prove public-interest impact under Hangman Ridge; a private right of action with discretionary trebling capped at $25,000 and one-way fees attaches automatically.

HIPAA reaches covered entities (health plans, healthcare clearinghouses, healthcare providers transmitting health information electronically in HIPAA transactions) and their business associates. A consumer-facing mental health SaaS without a provider relationship is usually neither. Direct-to-consumer therapy chatbots, journaling apps, mood trackers, peer-support apps, and AI mental health assistants typically sit outside HIPAA. The exemption at is data-specific, not entity-blanket: even an app that has some HIPAA-covered relationships still owes MHMDA duties on any consumer health data that is not PHI in a covered transaction.

For a side-by-side analysis of overlap, exemptions, and the practical posture for hybrid products, see my HIPAA vs MHMDA for Mental Health SaaS.

The third-party SDK trap. Most consumer-facing mental health apps load analytics, attribution, session replay, ad pixels, AI APIs, and customer support widgets that receive content from the screen. When that content is journal entries, mood logs, chat messages, or symptom inputs, every SDK call is a sharing event subject to . The fix is a documented vendor map, MHMDA processor contracts under , and either (a) shut off the data flow to the vendor, (b) collect a separate sharing consent for that specific vendor with a stated purpose, or (c) treat the vendor as a regulated entity for the data at issue. AI features that send free-text mental health content to a third-party model API are the most common gap I see.

The exposure profile differs by sub-category. I keep an issue page for each so the gap analysis stays specific to your product.

Sergei's practical note

The mental health SaaS category is where MHMDA actually changes behavior in practice. The product invites the user to disclose mental health status; the platform integrates with analytics, attribution, an AI model API, a CRM, and a support widget; and almost none of it has been mapped against the Washington statute. The fix is not aspirational policy text. It is a vendor map, MHMDA-compliant processor contracts under , an operational deletion workflow that actually reaches the AI vector store and the analytics warehouse, a separate Consumer Health Data Privacy Policy under , and two-layer consent at signup. I review mental health SaaS products under California license. This is regulatory advisory work, not Washington representation.

What I review and what the tiers cover

The work splits into a scope memo, a memo plus processor and consent fixes, and a memo plus a drafted Consumer Health Data Privacy Policy. For behavioral health products with multiple integrations, the SaaS bundle includes the vendor map, processor language, the policy, and the consent flow under California license. For the larger SaaS bundle, email me for current availability and scope confirmation.

Payment

Flat fee, paid up front through a secure PayPal checkout, so the budget is fixed before any work starts. The flat fee for the Healthcare SaaS Legal Package is $2,500. There is no hourly meter and no surprise invoice. If a matter is unusually large or turns into extended negotiation, I tell you before any additional work and we agree on scope first.

Delivery

Drafts in 2 to 3 business days, even for complex agreements. I work weekends when a matter needs it and it is engaged. You receive the work product by email in an editable format, with brief written comments explaining the key issues and the reasoning behind the main choices.

Process

Scope

This is attorney-supervised regulatory and document work under my California license: issue spotting, compliance planning, drafting, and review. It is not Washington court representation. For Washington filings, litigation, or any court appearance, I coordinate with Washington-admitted counsel. Nothing here creates an attorney-client relationship until a conflict check clears and an engagement is confirmed in writing.

Statutory sources retrieved 2026-05-19 from app.leg.wa.gov: RCW 19.373.010, .020, .030, .040, .050, .060, .080, .090, .100.

Educational resource. Sergei Tokmakov is a California attorney (CA Bar #279869) currently seeking admission to the Washington State Bar. Nothing on this page creates an attorney-client relationship or is Washington legal advice. A Washington-admitted attorney should verify operative statute text before relying on it in a live matter.